Loading company
$6.85+0.4%Nov 13 close
Figures through September 30, 2026, from the 10-Q filed November 12, 2026
Past performance
- 1W
- -7.1%
- 1M
- -22.5%
- 3M
- -9.2%
- 6M
- +96.3%
- 1Y
- -67.6%
- 5Y
- -99.5%
Bull, base and bear scenarios, opening on what this business has actually done — its realised growth rates and its own P/E range, not round numbers we chose.
Projections are part of Pro
Set the growth, margin and multiple yourself and watch the price land where your assumptions put it — for Akari Therapeutics, Plc and every other company we cover.
Try it first on NVDA, AAPL, META, NKE or CAKE, where it is open to everyone.
$6.85+0.4%Nov 13 close
Figures through September 30, 2026, from the 10-Q filed November 12, 2026